Nu Skin Enterprises, Inc. (NYSE:NUS) – Research analysts at Jefferies Financial Group cut their Q2 2019 EPS estimates for shares of Nu Skin Enterprises in a note issued to investors on Tuesday, April 30th, Zacks Investment Research reports. Jefferies Financial Group analyst S. Wissink now anticipates that the company will post earnings of $0.94 per share for the quarter, down from their prior forecast of $1.03. Jefferies Financial Group also issued estimates for Nu Skin Enterprises’ Q4 2019 earnings at $1.20 EPS, FY2019 earnings at $3.92 EPS, Q1 2020 earnings at $0.83 EPS, Q2 2020 earnings at $1.01 EPS, Q3 2020 earnings at $1.08 EPS, Q4 2020 earnings at $1.27 EPS and FY2020 earnings at $4.20 EPS.
NUS has been the subject of several other reports. Zacks Investment Research upgraded Nu Skin Enterprises from a “hold” rating to a “buy” rating and set a $75.00 target price for the company in a research note on Tuesday, February 12th. ValuEngine cut Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Wednesday, March 20th. Citigroup set a $86.00 target price on Nu Skin Enterprises and gave the stock a “buy” rating in a research note on Friday, February 15th. Bank of America restated an “underperform” rating and set a $65.00 target price on shares of Nu Skin Enterprises in a research note on Friday, April 12th. Finally, Pivotal Research reiterated a “buy” rating and issued a $85.00 price target on shares of Nu Skin Enterprises in a research note on Wednesday, February 13th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $73.75.
Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Tuesday, April 30th. The company reported $0.77 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.06. Nu Skin Enterprises had a return on equity of 26.81% and a net margin of 4.82%. The firm had revenue of $623.60 million during the quarter, compared to analysts’ expectations of $615.98 million. During the same period in the prior year, the company earned $0.79 earnings per share. The company’s quarterly revenue was up 1.2% on a year-over-year basis.
Several institutional investors and hedge funds have recently made changes to their positions in NUS. YorkBridge Wealth Partners LLC acquired a new stake in Nu Skin Enterprises in the fourth quarter valued at $31,000. Quadrant Capital Group LLC increased its holdings in Nu Skin Enterprises by 823.3% in the first quarter. Quadrant Capital Group LLC now owns 554 shares of the company’s stock valued at $26,000 after purchasing an additional 494 shares during the period. Meeder Asset Management Inc. acquired a new stake in Nu Skin Enterprises in the first quarter valued at $65,000. Investors Research Corp acquired a new stake in Nu Skin Enterprises in the first quarter valued at $73,000. Finally, Quantamental Technologies LLC acquired a new stake in Nu Skin Enterprises in the first quarter valued at $86,000. Institutional investors own 74.80% of the company’s stock.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 12th. Stockholders of record on Friday, May 31st will be paid a $0.37 dividend. This represents a $1.48 dividend on an annualized basis and a dividend yield of 2.90%. The ex-dividend date is Thursday, May 30th. Nu Skin Enterprises’s payout ratio is 42.05%.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic and personal care products.
Recommended Story: Earnings Per Share (EPS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.